Today in trading, Hls Therapeutics Inc shares closed at $5.04 after opening the day at $4.81. It traded at a low of $4.81 to a high of $5.48.

Share prices advanced 9.80% from the previous day's close of $4.59.

Today across North America, the TSX Composite closed 0.96% at 22264.38, the S&P 500 closed 1.11% at 5204.34, the Dow Jones Industrial Average closed 0.80% at 38904.04 and the Nasdaq Composite closed 1.24% at 16248.52.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 19,754 on 100 total trades, while having an average volume of 10,233 over the last 5-days.

Trading across the entire TSX saw 3,142 price advancers against 2,094 declines and 118 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -18.84 percent, while they have boosted 27.59% since the start of 2024.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $146.52 million on a float of 31,921 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc's average recommendation is "Moderate Buy" based on 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..